InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results

Bulletin Express

Yesterday

InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.

The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.

The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1118885332"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118885332\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118885332?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 17:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118885332","market":"hk","top_or_hot":-1,"title":"InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results","media":"Bulletin Express","content":"<p>InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.</p>\n<p>The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>\n<p>The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnoCare Schedules 24 Aug 2026 Board Meeting to Review 1H 2026 Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-11 17:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.</p>\n<p>The board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.</p>\n<p>The meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"诺诚健华","start_time":0,"source_url":"","article_id":"1118885332","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118885332","pubTimestamp":1786439384,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"诺诚健华计划于2026年8月24日召开董事会会议，以审阅2026年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"InnoCare Pharma Limited announced that its board of directors will convene on 24 August 2026 to consider and approve the interim financial results for the six months ended 30 June 2026, after which the results are expected to be published.\nThe board is led by Chairperson and Executive Director Dr. Jisong Cui, with Executive Director Dr. Renbin Zhao; Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie; and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.\nThe meeting date and agenda were disclosed in an announcement filed with Hong Kong Exchanges and Clearing Limited on 11 August 2026. All details have been released under the company’s statutory disclosure obligations, and no further financial figures were provided in the notice.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}